GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pheton Holdings Ltd (NAS:PTHL) » Definitions » Accumulated Depreciation

PTHL (Pheton Holdings) Accumulated Depreciation : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Pheton Holdings Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.


Pheton Holdings Accumulated Depreciation Historical Data

The historical data trend for Pheton Holdings's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pheton Holdings Accumulated Depreciation Chart

Pheton Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Accumulated Depreciation
- - - -

Pheton Holdings Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Accumulated Depreciation Get a 7-Day Free Trial - - - - -

Pheton Holdings Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


Pheton Holdings Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Pheton Holdings's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.


Pheton Holdings Business Description

Traded in Other Exchanges
N/A
Address
Hong Jun Ying South Road, Room 306, NET Building, Chaoyang District, Beijing, CHN, 100101
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

Pheton Holdings Headlines